0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Sulfonamides Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-36N5804
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Sulfonamides Market Insights Forecast to 2028
BUY CHAPTERS

Global Sulfonamides Market Insights, Forecast to 2030

Code: QYRE-Auto-36N5804
Report
December 2024
Pages:87
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Sulfonamides Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Sulfonamides Market

Sulfonamides Market

Sulfonamides (sulphonamides) is a man-made group of medicines that includes the sulfonamide chemical group. Which is also called sulfa drugs. Sulfonamide antimicrobials are bacteriostatic (helps to stop generating new bacteria, but don’t surely kill them) and also work by intervening with the fusion of folic acid in bacteria, which is important for the formation of nucleic acid and ultimately for DNA and RNA. Sulfonamides are generally used in the pharmaceutical industry at a high rate. Where it is used as bacteriostatic agents which helps to kill the bacteria from human as well as from the animal’s body. Sulfonamides can be prepared in many ways in the laboratory. Sulfonamides are generally used for diabetes, fluid retention, high blood pressure, crohn’s disease, etc.
Market Analysis and Insights: Global Sulfonamides Market
The global Sulfonamides market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Sulfonamides market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Sulfonamides, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Sulfonamides, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Sulfonamides revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Sulfonamides market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Sulfonamides revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Sulfonamides Market Report

Report Metric Details
Report Name Sulfonamides Market
CAGR 5%
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Pfizer, Sanofi, Roche, Mylan, Teva, Bayer, Abbott, GlaxoSmithKline, Boehringer Ingelheim
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Sulfonamides in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Sulfonamides companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 8: China by Type, and by Application, revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Sulfonamides revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Sulfonamides Market report?

Ans: The main players in the Sulfonamides Market are Pfizer, Sanofi, Roche, Mylan, Teva, Bayer, Abbott, GlaxoSmithKline, Boehringer Ingelheim

What are the Application segmentation covered in the Sulfonamides Market report?

Ans: The Applications covered in the Sulfonamides Market report are Systemic Infection, Intestinal Infection, Burn Infection, Other Infections

What are the Type segmentation covered in the Sulfonamides Market report?

Ans: The Types covered in the Sulfonamides Market report are Intestinal Absorption, Intestinal Tract Difficult to Absorb, External Use

Recommended Reports

Sulfa Drugs & APIs

Therapeutic Applications

Antibiotics & Anti-Infectives

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sulfonamides Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Intestinal Absorption
1.2.3 Intestinal Tract Difficult to Absorb
1.2.4 External Use
1.3 Market by Application
1.3.1 Global Sulfonamides Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Systemic Infection
1.3.3 Intestinal Infection
1.3.4 Burn Infection
1.3.5 Other Infections
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Sulfonamides Market Perspective (2019-2030)
2.2 Global Sulfonamides Growth Trends by Region
2.2.1 Sulfonamides Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Sulfonamides Historic Market Size by Region (2019-2024)
2.2.3 Sulfonamides Forecasted Market Size by Region (2025-2030)
2.3 Sulfonamides Market Dynamics
2.3.1 Sulfonamides Industry Trends
2.3.2 Sulfonamides Market Drivers
2.3.3 Sulfonamides Market Challenges
2.3.4 Sulfonamides Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Sulfonamides by Players
3.1.1 Global Sulfonamides Revenue by Players (2019-2024)
3.1.2 Global Sulfonamides Revenue Market Share by Players (2019-2024)
3.2 Global Sulfonamides Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Sulfonamides, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Sulfonamides Market Concentration Ratio
3.4.1 Global Sulfonamides Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sulfonamides Revenue in 2023
3.5 Global Key Players of Sulfonamides Head office and Area Served
3.6 Global Key Players of Sulfonamides, Product and Application
3.7 Global Key Players of Sulfonamides, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Sulfonamides Breakdown Data by Type
4.1 Global Sulfonamides Historic Market Size by Type (2019-2024)
4.2 Global Sulfonamides Forecasted Market Size by Type (2025-2030)
5 Sulfonamides Breakdown Data by Application
5.1 Global Sulfonamides Historic Market Size by Application (2019-2024)
5.2 Global Sulfonamides Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Sulfonamides Market Size (2019-2030)
6.2 North America Sulfonamides Market Size by Type
6.2.1 North America Sulfonamides Market Size by Type (2019-2024)
6.2.2 North America Sulfonamides Market Size by Type (2025-2030)
6.2.3 North America Sulfonamides Market Share by Type (2019-2030)
6.3 North America Sulfonamides Market Size by Application
6.3.1 North America Sulfonamides Market Size by Application (2019-2024)
6.3.2 North America Sulfonamides Market Size by Application (2025-2030)
6.3.3 North America Sulfonamides Market Share by Application (2019-2030)
6.4 North America Sulfonamides Market Size by Country
6.4.1 North America Sulfonamides Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Sulfonamides Market Size by Country (2019-2024)
6.4.3 North America Sulfonamides Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Sulfonamides Market Size (2019-2030)
7.2 Europe Sulfonamides Market Size by Type
7.2.1 Europe Sulfonamides Market Size by Type (2019-2024)
7.2.2 Europe Sulfonamides Market Size by Type (2025-2030)
7.2.3 Europe Sulfonamides Market Share by Type (2019-2030)
7.3 Europe Sulfonamides Market Size by Application
7.3.1 Europe Sulfonamides Market Size by Application (2019-2024)
7.3.2 Europe Sulfonamides Market Size by Application (2025-2030)
7.3.3 Europe Sulfonamides Market Share by Application (2019-2030)
7.4 Europe Sulfonamides Market Size by Country
7.4.1 Europe Sulfonamides Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Sulfonamides Market Size by Country (2019-2024)
7.4.3 Europe Sulfonamides Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Sulfonamides Market Size (2019-2030)
8.2 China Sulfonamides Market Size by Type
8.2.1 China Sulfonamides Market Size by Type (2019-2024)
8.2.2 China Sulfonamides Market Size by Type (2025-2030)
8.2.3 China Sulfonamides Market Share by Type (2019-2030)
8.3 China Sulfonamides Market Size by Application
8.3.1 China Sulfonamides Market Size by Application (2019-2024)
8.3.2 China Sulfonamides Market Size by Application (2025-2030)
8.3.3 China Sulfonamides Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Sulfonamides Market Size (2019-2030)
9.2 Asia Sulfonamides Market Size by Type
9.2.1 Asia Sulfonamides Market Size by Type (2019-2024)
9.2.2 Asia Sulfonamides Market Size by Type (2025-2030)
9.2.3 Asia Sulfonamides Market Share by Type (2019-2030)
9.3 Asia Sulfonamides Market Size by Application
9.3.1 Asia Sulfonamides Market Size by Application (2019-2024)
9.3.2 Asia Sulfonamides Market Size by Application (2025-2030)
9.3.3 Asia Sulfonamides Market Share by Application (2019-2030)
9.4 Asia Sulfonamides Market Size by Region
9.4.1 Asia Sulfonamides Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Sulfonamides Market Size by Region (2019-2024)
9.4.3 Asia Sulfonamides Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Sulfonamides Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Sulfonamides Market Size by Type
10.2.1 Middle East, Africa, and Latin America Sulfonamides Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Sulfonamides Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Sulfonamides Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Sulfonamides Market Size by Application
10.3.1 Middle East, Africa, and Latin America Sulfonamides Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Sulfonamides Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Sulfonamides Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Sulfonamides Market Size by Country
10.4.1 Middle East, Africa, and Latin America Sulfonamides Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Sulfonamides Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Sulfonamides Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Sulfonamides Introduction
11.1.4 Pfizer Revenue in Sulfonamides Business (2019-2024)
11.1.5 Pfizer Recent Developments
11.2 Sanofi
11.2.1 Sanofi Company Details
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Sulfonamides Introduction
11.2.4 Sanofi Revenue in Sulfonamides Business (2019-2024)
11.2.5 Sanofi Recent Developments
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Roche Business Overview
11.3.3 Roche Sulfonamides Introduction
11.3.4 Roche Revenue in Sulfonamides Business (2019-2024)
11.3.5 Roche Recent Developments
11.4 Mylan
11.4.1 Mylan Company Details
11.4.2 Mylan Business Overview
11.4.3 Mylan Sulfonamides Introduction
11.4.4 Mylan Revenue in Sulfonamides Business (2019-2024)
11.4.5 Mylan Recent Developments
11.5 Teva
11.5.1 Teva Company Details
11.5.2 Teva Business Overview
11.5.3 Teva Sulfonamides Introduction
11.5.4 Teva Revenue in Sulfonamides Business (2019-2024)
11.5.5 Teva Recent Developments
11.6 Bayer
11.6.1 Bayer Company Details
11.6.2 Bayer Business Overview
11.6.3 Bayer Sulfonamides Introduction
11.6.4 Bayer Revenue in Sulfonamides Business (2019-2024)
11.6.5 Bayer Recent Developments
11.7 Abbott
11.7.1 Abbott Company Details
11.7.2 Abbott Business Overview
11.7.3 Abbott Sulfonamides Introduction
11.7.4 Abbott Revenue in Sulfonamides Business (2019-2024)
11.7.5 Abbott Recent Developments
11.8 GlaxoSmithKline
11.8.1 GlaxoSmithKline Company Details
11.8.2 GlaxoSmithKline Business Overview
11.8.3 GlaxoSmithKline Sulfonamides Introduction
11.8.4 GlaxoSmithKline Revenue in Sulfonamides Business (2019-2024)
11.8.5 GlaxoSmithKline Recent Developments
11.9 Boehringer Ingelheim
11.9.1 Boehringer Ingelheim Company Details
11.9.2 Boehringer Ingelheim Business Overview
11.9.3 Boehringer Ingelheim Sulfonamides Introduction
11.9.4 Boehringer Ingelheim Revenue in Sulfonamides Business (2019-2024)
11.9.5 Boehringer Ingelheim Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Sulfonamides Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Intestinal Absorption
    Table 3. Key Players of Intestinal Tract Difficult to Absorb
    Table 4. Key Players of External Use
    Table 5. Global Sulfonamides Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 6. Global Sulfonamides Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 7. Global Sulfonamides Market Size by Region (2019-2024) & (US$ Million)
    Table 8. Global Sulfonamides Market Share by Region (2019-2024)
    Table 9. Global Sulfonamides Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 10. Global Sulfonamides Market Share by Region (2025-2030)
    Table 11. Sulfonamides Market Trends
    Table 12. Sulfonamides Market Drivers
    Table 13. Sulfonamides Market Challenges
    Table 14. Sulfonamides Market Restraints
    Table 15. Global Sulfonamides Revenue by Players (2019-2024) & (US$ Million)
    Table 16. Global Sulfonamides Revenue Share by Players (2019-2024)
    Table 17. Global Top Sulfonamides by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sulfonamides as of 2023)
    Table 18. Global Sulfonamides Industry Ranking 2022 VS 2023 VS 2024
    Table 19. Global 5 Largest Players Market Share by Sulfonamides Revenue (CR5 and HHI) & (2019-2024)
    Table 20. Global Key Players of Sulfonamides, Headquarters and Area Served
    Table 21. Global Key Players of Sulfonamides, Product and Application
    Table 22. Global Key Players of Sulfonamides, Product and Application
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Sulfonamides Market Size by Type (2019-2024) & (US$ Million)
    Table 25. Global Sulfonamides Revenue Market Share by Type (2019-2024)
    Table 26. Global Sulfonamides Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 27. Global Sulfonamides Revenue Market Share by Type (2025-2030)
    Table 28. Global Sulfonamides Market Size by Application (2019-2024) & (US$ Million)
    Table 29. Global Sulfonamides Revenue Share by Application (2019-2024)
    Table 30. Global Sulfonamides Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 31. Global Sulfonamides Revenue Share by Application (2025-2030)
    Table 32. North America Sulfonamides Market Size by Type (2019-2024) & (US$ Million)
    Table 33. North America Sulfonamides Market Size by Type (2025-2030) & (US$ Million)
    Table 34. North America Sulfonamides Market Size by Application (2019-2024) & (US$ Million)
    Table 35. North America Sulfonamides Market Size by Application (2025-2030) & (US$ Million)
    Table 36. North America Sulfonamides Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 37. North America Sulfonamides Market Size by Country (2019-2024) & (US$ Million)
    Table 38. North America Sulfonamides Market Size by Country (2025-2030) & (US$ Million)
    Table 39. Europe Sulfonamides Market Size by Type (2019-2024) & (US$ Million)
    Table 40. Europe Sulfonamides Market Size by Type (2025-2030) & (US$ Million)
    Table 41. Europe Sulfonamides Market Size by Application (2019-2024) & (US$ Million)
    Table 42. Europe Sulfonamides Market Size by Application (2025-2030) & (US$ Million)
    Table 43. Europe Sulfonamides Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 44. Europe Sulfonamides Market Size by Country (2019-2024) & (US$ Million)
    Table 45. Europe Sulfonamides Market Size by Country (2025-2030) & (US$ Million)
    Table 46. China Sulfonamides Market Size by Type (2019-2024) & (US$ Million)
    Table 47. China Sulfonamides Market Size by Type (2025-2030) & (US$ Million)
    Table 48. China Sulfonamides Market Size by Application (2019-2024) & (US$ Million)
    Table 49. China Sulfonamides Market Size by Application (2025-2030) & (US$ Million)
    Table 50. Asia Sulfonamides Market Size by Type (2019-2024) & (US$ Million)
    Table 51. Asia Sulfonamides Market Size by Type (2025-2030) & (US$ Million)
    Table 52. Asia Sulfonamides Market Size by Application (2019-2024) & (US$ Million)
    Table 53. Asia Sulfonamides Market Size by Application (2025-2030) & (US$ Million)
    Table 54. Asia Sulfonamides Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 55. Asia Sulfonamides Market Size by Region (2019-2024) & (US$ Million)
    Table 56. Asia Sulfonamides Market Size by Region (2025-2030) & (US$ Million)
    Table 57. Middle East, Africa, and Latin America Sulfonamides Market Size by Type (2019-2024) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Sulfonamides Market Size by Type (2025-2030) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Sulfonamides Market Size by Application (2019-2024) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Sulfonamides Market Size by Application (2025-2030) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Sulfonamides Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 62. Middle East, Africa, and Latin America Sulfonamides Market Size by Country (2019-2024) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Sulfonamides Market Size by Country (2025-2030) & (US$ Million)
    Table 64. Pfizer Company Details
    Table 65. Pfizer Business Overview
    Table 66. Pfizer Sulfonamides Product
    Table 67. Pfizer Revenue in Sulfonamides Business (2019-2024) & (US$ Million)
    Table 68. Pfizer Recent Developments
    Table 69. Sanofi Company Details
    Table 70. Sanofi Business Overview
    Table 71. Sanofi Sulfonamides Product
    Table 72. Sanofi Revenue in Sulfonamides Business (2019-2024) & (US$ Million)
    Table 73. Sanofi Recent Developments
    Table 74. Roche Company Details
    Table 75. Roche Business Overview
    Table 76. Roche Sulfonamides Product
    Table 77. Roche Revenue in Sulfonamides Business (2019-2024) & (US$ Million)
    Table 78. Roche Recent Developments
    Table 79. Mylan Company Details
    Table 80. Mylan Business Overview
    Table 81. Mylan Sulfonamides Product
    Table 82. Mylan Revenue in Sulfonamides Business (2019-2024) & (US$ Million)
    Table 83. Mylan Recent Developments
    Table 84. Teva Company Details
    Table 85. Teva Business Overview
    Table 86. Teva Sulfonamides Product
    Table 87. Teva Revenue in Sulfonamides Business (2019-2024) & (US$ Million)
    Table 88. Teva Recent Developments
    Table 89. Bayer Company Details
    Table 90. Bayer Business Overview
    Table 91. Bayer Sulfonamides Product
    Table 92. Bayer Revenue in Sulfonamides Business (2019-2024) & (US$ Million)
    Table 93. Bayer Recent Developments
    Table 94. Abbott Company Details
    Table 95. Abbott Business Overview
    Table 96. Abbott Sulfonamides Product
    Table 97. Abbott Revenue in Sulfonamides Business (2019-2024) & (US$ Million)
    Table 98. Abbott Recent Developments
    Table 99. GlaxoSmithKline Company Details
    Table 100. GlaxoSmithKline Business Overview
    Table 101. GlaxoSmithKline Sulfonamides Product
    Table 102. GlaxoSmithKline Revenue in Sulfonamides Business (2019-2024) & (US$ Million)
    Table 103. GlaxoSmithKline Recent Developments
    Table 104. Boehringer Ingelheim Company Details
    Table 105. Boehringer Ingelheim Business Overview
    Table 106. Boehringer Ingelheim Sulfonamides Product
    Table 107. Boehringer Ingelheim Revenue in Sulfonamides Business (2019-2024) & (US$ Million)
    Table 108. Boehringer Ingelheim Recent Developments
    Table 109. Research Programs/Design for This Report
    Table 110. Key Data Information from Secondary Sources
    Table 111. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Sulfonamides Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Sulfonamides Market Share by Type: 2023 VS 2030
    Figure 3. Intestinal Absorption Features
    Figure 4. Intestinal Tract Difficult to Absorb Features
    Figure 5. External Use Features
    Figure 6. Global Sulfonamides Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 7. Global Sulfonamides Market Share by Application: 2023 VS 2030
    Figure 8. Systemic Infection Case Studies
    Figure 9. Intestinal Infection Case Studies
    Figure 10. Burn Infection Case Studies
    Figure 11. Other Infections Case Studies
    Figure 12. Sulfonamides Report Years Considered
    Figure 13. Global Sulfonamides Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 14. Global Sulfonamides Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 15. Global Sulfonamides Market Share by Region: 2023 VS 2030
    Figure 16. Global Sulfonamides Market Share by Players in 2023
    Figure 17. Global Top Sulfonamides Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sulfonamides as of 2023)
    Figure 18. The Top 10 and 5 Players Market Share by Sulfonamides Revenue in 2023
    Figure 19. North America Sulfonamides Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 20. North America Sulfonamides Market Share by Type (2019-2030)
    Figure 21. North America Sulfonamides Market Share by Application (2019-2030)
    Figure 22. North America Sulfonamides Market Share by Country (2019-2030)
    Figure 23. United States Sulfonamides Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Canada Sulfonamides Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Europe Sulfonamides Market Size YoY (2019-2030) & (US$ Million)
    Figure 26. Europe Sulfonamides Market Share by Type (2019-2030)
    Figure 27. Europe Sulfonamides Market Share by Application (2019-2030)
    Figure 28. Europe Sulfonamides Market Share by Country (2019-2030)
    Figure 29. Germany Sulfonamides Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. France Sulfonamides Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. U.K. Sulfonamides Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Italy Sulfonamides Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Russia Sulfonamides Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Nordic Countries Sulfonamides Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. China Sulfonamides Market Size YoY (2019-2030) & (US$ Million)
    Figure 36. China Sulfonamides Market Share by Type (2019-2030)
    Figure 37. China Sulfonamides Market Share by Application (2019-2030)
    Figure 38. Asia Sulfonamides Market Size YoY (2019-2030) & (US$ Million)
    Figure 39. Asia Sulfonamides Market Share by Type (2019-2030)
    Figure 40. Asia Sulfonamides Market Share by Application (2019-2030)
    Figure 41. Asia Sulfonamides Market Share by Region (2019-2030)
    Figure 42. Japan Sulfonamides Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. South Korea Sulfonamides Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. China Taiwan Sulfonamides Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Southeast Asia Sulfonamides Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. India Sulfonamides Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Australia Sulfonamides Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Middle East, Africa, and Latin America Sulfonamides Market Size YoY (2019-2030) & (US$ Million)
    Figure 49. Middle East, Africa, and Latin America Sulfonamides Market Share by Type (2019-2030)
    Figure 50. Middle East, Africa, and Latin America Sulfonamides Market Share by Application (2019-2030)
    Figure 51. Middle East, Africa, and Latin America Sulfonamides Market Share by Country (2019-2030)
    Figure 52. Brazil Sulfonamides Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Mexico Sulfonamides Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Turkey Sulfonamides Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Saudi Arabia Sulfonamides Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Israel Sulfonamides Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. GCC Countries Sulfonamides Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. Pfizer Revenue Growth Rate in Sulfonamides Business (2019-2024)
    Figure 59. Sanofi Revenue Growth Rate in Sulfonamides Business (2019-2024)
    Figure 60. Roche Revenue Growth Rate in Sulfonamides Business (2019-2024)
    Figure 61. Mylan Revenue Growth Rate in Sulfonamides Business (2019-2024)
    Figure 62. Teva Revenue Growth Rate in Sulfonamides Business (2019-2024)
    Figure 63. Bayer Revenue Growth Rate in Sulfonamides Business (2019-2024)
    Figure 64. Abbott Revenue Growth Rate in Sulfonamides Business (2019-2024)
    Figure 65. GlaxoSmithKline Revenue Growth Rate in Sulfonamides Business (2019-2024)
    Figure 66. Boehringer Ingelheim Revenue Growth Rate in Sulfonamides Business (2019-2024)
    Figure 67. Bottom-up and Top-down Approaches for This Report
    Figure 68. Data Triangulation
    Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network